R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology Assessment.
暂无分享,去创建一个
Gianluca Baio | Devin Incerti | Howard Thom | Jeroen P Jansen | G. Baio | J. Jansen | H. Thom | D. Incerti
[1] Christopher McCabe,et al. A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models , 2017, PharmacoEconomics.
[2] M. Sculpher,et al. Representing uncertainty: the role of cost-effectiveness acceptability curves. , 2001, Health economics.
[3] Deborah M Caldwell,et al. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis , 2017, BMJ.
[4] D. Owens,et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[5] M. Sculpher,et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. , 2005, Health economics.
[6] Alan Edelman,et al. Julia: A Fresh Approach to Numerical Computing , 2014, SIAM Rev..
[7] Hadley Wickham,et al. testthat: Get Started with Testing , 2011, R J..
[8] K. Chalkidou. About the National Institute for Health and Care Excellence - NICE. , 2013, Acta medica portuguesa.
[9] Andrew Glover,et al. Continuous Integration: Improving Software Quality and Reducing Risk (The Addison-Wesley Signature Series) , 2007 .
[10] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[11] Jeffrey W. Eaton,et al. HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa , 2012, PLoS medicine.
[12] Guido Van Rossum,et al. Python Tutorial , 1999 .
[13] Gianluca Baio,et al. Bayesian Methods in Health Economics , 2012 .
[14] Peter Bryden,et al. Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis. , 2017, Health technology assessment.
[15] Nicolas A. Menzies,et al. Bayesian Methods for Calibrating Health Policy Models: A Tutorial , 2017, PharmacoEconomics.
[16] Hein Putter,et al. Reduced-rank proportional hazards regression and simulation-based prediction for multi-state models. , 2008, Statistics in medicine.
[17] G. Chowell,et al. Transmission dynamics and control of Ebola virus disease (EVD): a review , 2014, BMC Medicine.
[18] J. de Haes,et al. Quality-adjusted survival analysis. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Jeroen P. Jansen,et al. Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes , 2012 .
[20] H Putter,et al. Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.
[21] Fernando Alarid-Escudero,et al. Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial , 2018, Medical decision making : an international journal of the Society for Medical Decision Making.
[22] Gianluca Baio,et al. Estimating the expected value of partial perfect information in health economic evaluations using integrated nested Laplace approximation , 2015, Statistics in medicine.
[23] Viral B. Shah,et al. Julia: A Fresh Approach to Numerical Computing | SIAM Review | Vol. 59, No. 1 | Society for Industrial and Applied Mathematics , 2017 .
[24] Claire Williams,et al. Cost-effectiveness Analysis in R Using a Multi-state Modeling Survival Analysis Framework: A Tutorial , 2016, Medical decision making : an international journal of the Society for Medical Decision Making.
[25] Fernando Alarid-Escudero,et al. An Overview of R in Health Decision Sciences , 2017, Medical decision making : an international journal of the Society for Medical Decision Making.
[26] Raffaele Vardavas,et al. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] Jeremy E. Oakley,et al. Estimating the Expected Value of Sample Information Using the Probabilistic Sensitivity Analysis Sample , 2015, Medical decision making : an international journal of the Society for Medical Decision Making.
[28] Andrew H Briggs,et al. Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[29] Gianluca Baio,et al. Efficient Monte Carlo Estimation of the Expected Value of Sample Information Using Moment Matching , 2016, Medical decision making : an international journal of the Society for Medical Decision Making.
[30] Nicky J Welton,et al. NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials , 2011 .
[31] Nicky J Welton,et al. Network Meta-Analysis for Decision-Making , 2018 .
[32] Ren Johansen. An Empirical Transition Matrix for Non-homogeneous Markov Chains Based on Censored Observations , 1978 .
[33] Klas Bergenheim,et al. Assessing the Relationship between Computational Speed and Precision , 2012, PharmacoEconomics.